bladder victims'treatment hope

Patients with bladder cancer could receive more targeted therapy thanks to a new discovery. A protein found in bladder tumours predicts whether people will benefit more from a course of radio-therapy or surgery to treat their cancer.

Some 70 per cent of patients with a high quantity of the DNA repair protein MRE11 survived at least three years after radiotherapy compared with about 40 per cent of those with low levels of the protein.

The work involved experts at the Leeds Institute of Molecular Medicine.

Related topics: